Free Trial Information
BioCentury | Aug 29, 2019
Emerging Company Profile

Hesperos: uniting organs on a chip

...system to show Gleevec imatinib reduced cancer proliferation within minimal effect on liver functionality, while diclofenac...
Read More
BioCentury | Apr 19, 2019
Clinical News

Pfizer, Lilly to mull anti-NGF mAb's future after joint safety events spike in long-term readout

...of 2.5 or 5 mg tanezumab every eight weeks, or oral NSAIDs naproxen, celecoxib or diclofenac...
Read More
BioCentury | Oct 26, 2018
Clinical News

Detailed data for Pfizer, Lilly anti-NGF mAb highlighted at ACR/ARHP

...in 1H19 from the Phase III A4091058 trial evaluating tanezumab compared with naproxen, celecoxib or diclofenac...
Read More
BioCentury | Oct 24, 2018
Clinical News

Detailed data for Pfizer, Lilly anti-NGF mAb highlighted at ACR/ARHP

...in 1H19 from the Phase III A4091058 trial evaluating tanezumab compared with naproxen, celecoxib or diclofenac...
Read More
BioCentury | Jan 6, 2018
Finance

Burgeoning bellwethers

...NASDAQ:FOMX) FMX103 Moderate to severe papulopustular rosacea Top-line Ph III data Mid-2018 Futura Medical plc (LSE:FUM) Diclofenac...
Read More
BioCentury | Aug 8, 2017
Company News

Depomed plummets on reduced sales guidance

...therefore increase its sales focus on post-herpetic neuralgia drug Gralise gabapentin and migraine drug Cambia diclofenac...
Read More
BioCentury | Jul 27, 2017
Product R&D

Spheres of influence

...studies. In 2013, InSphero showed its hLiMTs survived five weeks, were sensitive to acetaminophen and diclofenac...
Read More
BioCentury | May 16, 2017
Distillery Therapeutics

Autoimmune disease; neurology

...of adjuvant-induced pain, the compound decreased mechanical hyperalgesia with comparable potency to the generic NSAID diclofenac...
Read More
BioCentury | Jan 13, 2017
Company News

Futura, Stada Arzneimittel deal

...inquiries. Futura Medical plc (LSE:FUM), Guildford, U.K. Stada Arzneimittel AG (Xetra:SAZ), Bad Vilbel, Germany Business: Neurology Nora Weintraub TPR100 Futura Medical...
Read More
BioCentury | Oct 31, 2016
Financial News

Futura Medical completes placing

Futura Medical plc (LSE:FUM), Guildford, U.K. Business: Drug delivery, Neurology, Genitourinary Date completed: 2016-10-27 Type: Placing Raised: L12 million ($14.7 million) Shares: 21.1 million Price: 57p Shares after offering: 120.1 million Placement agent: N+1 Singer...
Read More
Items per page:
1 - 10 of 431